BRENDA SIMMONS: Open Payments
NPI 1285814954 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $81 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| Amgen Inc. | 2 | $43 |
| Radius Health, Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $24 |
| Boston Scientific Corporation | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $14 |
Products named: AIRSUPRA, Kerendia, OTEZLA, Tymlos, QULIPTA, WATCHMAN Access System, ZORYVE, Wegovy.
Industry payments across NV — which companies pay providers there.
